Clinical use of p-proteasome in discriminating metastatic melanoma patients: Comparative study with LDH, MIA and S100B protein
about
Covalent small molecule inhibitors of Ca(2+)-bound S100B.Small Molecule Inhibitors of Ca(2+)-S100B Reveal Two Protein Conformations.Melanoma inhibitory activity in Brazilian patients with cutaneous melanoma.Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis.Melanoma inhibitory activity in melanoma diagnostics and therapy - a small protein is looming large.
P2860
Clinical use of p-proteasome in discriminating metastatic melanoma patients: Comparative study with LDH, MIA and S100B protein
description
im Januar 2013 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2013
@uk
name
Clinical use of p-proteasome i ...... ith LDH, MIA and S100B protein
@en
Clinical use of p-proteasome i ...... ith LDH, MIA and S100B protein
@nl
type
label
Clinical use of p-proteasome i ...... ith LDH, MIA and S100B protein
@en
Clinical use of p-proteasome i ...... ith LDH, MIA and S100B protein
@nl
prefLabel
Clinical use of p-proteasome i ...... ith LDH, MIA and S100B protein
@en
Clinical use of p-proteasome i ...... ith LDH, MIA and S100B protein
@nl
P2093
P2860
P356
P1476
Clinical use of p-proteasome i ...... ith LDH, MIA and S100B protein
@en
P2093
Cécile Fabre
Isabelle Guiraud
Laurent Henry
Laurent Meunier
Pierre-Emmanuel Stoebner
Sophie Bastide
Thierry Lavabre-Bertrand
P2860
P304
P356
10.1002/IJC.27991
P577
2013-01-15T00:00:00Z